Conversely, the CSF was enriched with CD20+ T cells (in both the CD4 and CD8 compartments) compared to the peripheral blood in 25 RR-MS [13] and 25 untreated PP-MS patients; these results were validated in a replication cohort including 16 untreated PP-MS [32]. The gene discussed is CD4; the disease is myeloid sarcoma.